KNF diaphragm liquid pumps combine maximum performance with minimum size. The use of chemically resistant...
KNF and DYMIND: A Decade of Collaboration Advancing Hematology Analysis
For more than a decade, KNF diaphragm pump solutions have helped DYMIND continuously improve and optimize state-of-the-art medical technology.

DYMIND Biotechnology Co., Ltd., an innovative high-tech medical company based in Shenzhen, China, has grown from a small start-up to a global player in medical diagnostics such as hematology analysis. Throughout this journey, KNF has remained a steadfast partner, providing critical pump technology to support DYMIND's continued success.
Powering Precision in Hematology Analysis
Hematology is an essential part of clinical diagnostics that focuses on the examination and analysis of blood, blood-forming organs and blood-related diseases. It includes a wide range of diagnostic methods and tests to evaluate various blood components, including red blood cells, white blood cells, platelets, hemoglobin and plasma. These tests are essential for identifying and monitoring many conditions, including anemia, coagulation disorders, infections and blood cancers.
To provide reliable and fast results in this vital field and to help improve patient care by enabling earlier and more accurate diagnosis, DYMIND hematology analyzers feature state-of-the-art technology, comprehensive testing capabilities, efficient throughput and sophisticated data management. At the heart of these systems are customized KNF diaphragm pumps that ensure precise fluid handling for accurate test results.
A Decade of Partnership and Innovation
DYMIND places a strong emphasis on innovation, which translates into the company's personnel structure and investments: A key part of the workforce is dedicated to research and development, and a significant proportion of annual turnover is invested in this area, reinforcing DYMIND's strong commitment to the continuous development and improvement of its products and services.
Since 2013, DYMIND has been relying on KNF pumps for the further development of its diagnostic instruments. As the company grew from a start-up to a major medical device manufacturer with over 1,000 employees, KNF provided ongoing support. Today, KNF pumps play a critical role in DYMIND's 5-part hematology analyzers such as the DM79X, D7-CRP and DF55, as well as coagulation analyzers and other related medical instruments.
The DM79X 5-Part Hematology Analyzer, for example, is equipped with reliable and precise KNF NF 30 liquid diaphragm pumps to transfer waste fluids, a critical function for maintaining system cleanliness and accuracy. They offer a flow rate of 0.3 l/min, a pressure of 1 bar rel. and a suction head of 6 mH2O. This, along with their self-priming and dry-running capabilities and maintenance-free design, ensures reliable performance in analytical instruments.
Commitment to Quality and Support
KNF pumps are particularly suitable for use in the medical industry and diagnostic instruments because they are reliable, easy to integrate and designed for easy maintenance when needed. But the commitment to excellence at KNF goes beyond pump technology: Providing a high standard of pre- and post-sales support has been instrumental in DYMIND's rapid growth. "KNF pumps are the cornerstone of DYMIND's quality assurance, enabling us to consistently meet and exceed the most stringent industry standards in medical diagnostics," explains an engineering representative at DYMIND Biotechnology Co., Ltd.
The partnership, which spans more than a decade, has been characterized by mutual trust, innovation, and a shared commitment to advancing technology. This commitment was further recognized when KNF received DYMIND's "Best Quality Award" in 2022 and the "Quality Excellence Award" in late 2024, highlighting the enduring partnership between the two companies.
As DYMIND has expanded its reach to more than 140 countries, KNF pump solutions have consistently met the evolving needs of the company's sophisticated diagnostic equipment, and KNF is proud to be part of DYMIND's journey from a small medical start-up to a global leader in diagnostic solutions.


